Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats

Peptides

Volumn 28, Issue 6, 2007, Pages 1214-1219

  Obay, Basra Deniz ^a   Tasdemir, Ezel ^b   Tümer, Cemil ^c   Bilgin, Hakki Murat ^a   Sermet, Abdurrahman ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Developmental Medical Center Diyarbakir   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Epilepsy; Ghrelin; Pentylenetetrazole (PTZ)

Indexed keywords

GHRELIN; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFECT; EPILEPSY; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TENDON REFLEX; TONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; PENTYLENETETRAZOLE; PEPTIDE HORMONES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEIZURES; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 34249694588     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.04.003     Document Type: Article

References (34)

1. Banks W.A., Tschop M., Robinson S.M., and Heiman M. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302 (2002) 822-827
2. Baraban S.C., Holopeter G., Erickson J.S., Schwartzkroin P.A., and Palmiter R.D. Knockout mice reveal a critical anti-epileptic role for neuropeptide Y. J Neurosci 17 (1997) 8927-8936
3. Ben-Menachem E., Hellstrom K., Waldton C., and Augustinsson L.E. Evaluation of refractory epilepsy treated with vagus nevre stimulation for up to 5 years. Neurology 52 (1999) 265-267
4. Berilgen M.S., Mungen B., Üstündaǧ B., and Demir C. Serum ghrelin levels are enhanced in patients with epilepsy. Seizure 15 (2006) 106-111
5. Colmers W.F., and Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17 (1994) 373-379
6. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411 (2001) 480-484
7. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 4 (2003) 649-661
8. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 4 (2002) 1120-1128
9. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-418
10. Greco R., Latini G., Chiarelli F., Ianetti P., and Verotti A. Leptin, ghrelin, and adinopectin in epileptic patients treated with valproic acid. Neurology 65 11 (2005) 1808-1809
11. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., and Kojima M. Ghrelin, a novel placental-derived hormone. Endocrinology 142 (2001) 788-794
12. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Siriathsinghi D.J., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48 (1997) 23-29
13. Handforth A., DeGiorgio C.M., Schachter S.C., Uthman B.M., Naritoku D.K., Tecoma E.S., et al. Vagus nevre stimulation therapy for partial onset seizures. A randomised active-control trial. Neurology 51 (1998) 48-55
14. Hansen S.L., Sperling B., and Sanchez C. Anticonvulsant and antiepileptogenic effect of GABA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuro Psychopharmacol Biol Psychiatry 28 (2004) 105-113
15. Heinemann U., and Jones R.S.G. Neurophysiology. In: Dam M., and Gram L. (Eds). Comprehensive epileptology (1990), Raven Press, New York 17-42
16. Klapstein G.J., and Colmers W.F. Neuropeptide Y supresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78 (1997) 1651-1661
17. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 6762 (1999) 656-660
18. Lu S., Guan J.L., Wang Q.P., Uehara K., Yamada S., Goto N., et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321 (2002) 157-160
19. Macdonalds R.L. Cellular effects of antiepileptic drugs. In: Engel Jr., and Pedley T.A. (Eds). Epilepsy. A comprehensive textbook (1997), Lippincott-Raven, New York 1383-1391
20. Mori K., Yoshimoto A., Takaya K., Hosoda K., and Ariyasu H. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486 (2000) 213-216
21. Morimoto K., Fahnestock M., and Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73 (2004) 1-60
22. Ness-Abramof R., and Apovian C.M. Drug-induced weight gain. Drugs Today (Barc) 41 (2005) 547-555
23. Ramanjaneyulu R., and Ticku M.K. İnteractions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol 98 (1984) 337-345
24. Sajdyk T.J., Shekhar A., and Gehlert D.R. Interaction between NPY and CRF in the amygdala regulate emotionality. Neuropeptides 38 4 (2004) 225-234
25. Shuto Y., Shibasaki T., Wada K., Parhar I., Kamegai J., Sugihara H., et al. Generation of polyclonal antiserum against the growth hormone secretagogue receptors (GHS-R): evidence that the GHS-R exist in the hypothalamus, pituitary and stomach of rats. Life Sci (2001) 991-996
26. Smialowska M., Bijak M., Sopala M., and Tokarski K. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides 30 (1996) 7
27. Simith R.G., Leonard R., Bailey A.R., Palyha O., Feighner S., Tan C., et al. Growth hormone secretagogue receptor family members and ligands. Endocrine 14 (2001) 9-14
28. Stroud L.M., O'Brien T.J., Jupp B., Wallengren C., and Morris M.J. Neuropeptide Y suppresses absence seizures in a genetic rat model. Brain Res 1033 (2005) 151-156
29. Tannenbaum G.S., Lapointe M., Beaudet A., and Howard A.D. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139 (1998) 4420-4424
30. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., and Gaytan F. Novel expression and functional role of ghrelin in rat testis. Endocrinology 143 (2002) 717-725
31. The Vagus nevre Stimulation Study Group E01-E05, Morris III G.L., and Mueller W.M. Long-term treatment with vagus nevre stimulation in patients refractory epilepsy. Neurology 53 (1999) 1731-1735
32. Willesen M.G., Kristensen P., and Romer J. Co-localization of growth hormone secretagogue receptors and NPYmRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 (1999) 306-316
33. Woldbye D.P.D., Madsen T.M., Larsen P.J., Mikkelsen J.D., and Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 737 (1996) 162-168
34. Woldbye D.P.D., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., and Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med 3 (1997) 761-764